LadyStanley
Registered User
ALS drug wins FDA approval despite questionable data
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The Food and Drug Administration approved the drug from Amylyx...
news.yahoo.com
Science marches forward